Accelagen Plus Surgical Matrix, 1cc (CG-01AP) +4 more— 510(k) K260711

Substantially Equivalent

Berkeley Advanced Biomaterials

FDA 510(k) clearance K260711 for Accelagen Plus Surgical Matrix, 1cc (CG-01AP) +4 more, Substantially Equivalent on 2026-08-27. Applicant: Berkeley Advanced Biomaterials. Device class: Unclassified.

Summary

Berkeley Advanced Biomaterials filed Accelagen Plus in five listed sizes: Surgical Matrix in 1cc, 3cc, and 5cc (CG-01AP, CG-03AP, CG-05AP) and Surgical Strip in 125x25x2mm and 250x25x2mm (CG-125X25AP, CG-250X25AP). The product code is KGN, wound dressings with animal-derived material.

The device class is listed as U, with no regulation number, and the classification panel is listed as Unknown. The General and Plastic Surgery review panel handled it as a Traditional 510(k).

The applicant filed from Berkeley, California. The decision came 175 calendar days after receipt (March 5 to August 27, 2026), and it was substantially equivalent.

Clearance details

Device name as filed
Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP)
Applicant
Berkeley Advanced Biomaterials
Product code
Product code KGN
Device class
Unclassified
Advisory panel
Unknown
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Berkeley, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code KGN

view all

More clearances from Berkeley Advanced Biomaterials

view all

Adverse events under product code KGN

product code KGN
Other
2
Total
2

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.